Unplanned medical interventions in hemodialysis: a real-world study of hypertonic glucose bolus for intradialytic hypotension

Intradialytic hypotension (IDH) is a common complication during hemodialysis, often managed with hypertonic glucose bolus. However, single-center real-world data on its clinical characteristics and impact on dialysis adequacy are limited. This single-center, retrospective real-world study included 450 prevalent hemodialysis patients followed for one year (2025). Unplanned medical interventions were extracted from the billing system. Clinical characteristics of hypertonic glucose bolus for IDH were analyzed, including dose, timing, hemodynamic response, and glycemic response. Dialysis outcomes (Kt/V, ultrafiltration achievement, treatment time) were compared between sessions with and without glucose bolus for IDH. Factors associated with IDH frequency were identified by multivariate linear regression. A total of 4,268 unplanned interventions were recorded, with glucose bolus for IDH being the most frequent (2,734 events, 64.1%) but accounting for only 1.9% of the total costs of all unplanned interventions. Glucose bolus rapidly increased systolic blood pressure (15.2 ± 5.8 mmHg) within 5 min, with effects lasting 65.8 ± 22.5 min. Diabetic patients showed greater pressure response and longer duration compared to non-diabetics. Sessions with glucose bolus achieved significantly higher Kt/V (1.44 ± 0.20 vs. 1.28 ± 0.24, P < 0.001), ultrafiltration completion rate (94.8% vs. 80.2%, P < 0.001), and lower premature termination rate (5.7% vs. 19.9%, P < 0.001) compared to sessions without glucose bolus. Kt/V > 2.0 was independently associated with increased IDH frequency (β = 7.18, P < 0.001). Hypertonic glucose bolus is a frequent, low-cost intervention that was associated with restoration of blood pressure and allowed patients to complete dialysis, thereby achieving adequate Kt/V. However, excessively high Kt/V may predispose patients to recurrent IDH, warranting careful prescription adjustment.

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2026-10-13
DOI
https://doi.org/10.1186/s12882-026-05442-7
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unplanned medical interventions in hemodialysis: a real-world study of hypertonic glucose bolus for intradialytic hypotension

Xishan Xiong, Huishang Wang, Juan Zhang, Shanshan Fan et al.
BMC Nephrology
Dialysis and Renal Disease Management
article

Unplanned medical interventions in hemodialysis: a real-world study of hypertonic glucose bolus for intradialytic hypotension

Xishan Xiong, Huishang Wang, Juan Zhang, Shanshan Fan, Shan Wu, Yuhong Wu, Hang Xu
article en

Abstract

Intradialytic hypotension (IDH) is a common complication during hemodialysis, often managed with hypertonic glucose bolus. However, single-center real-world data on its clinical characteristics and impact on dialysis adequacy are limited. This single-center, retrospective real-world study included 450 prevalent hemodialysis patients followed for one year (2025). Unplanned medical interventions were extracted from the billing system. Clinical characteristics of hypertonic glucose bolus for IDH were analyzed, including dose, timing, hemodynamic response, and glycemic response. Dialysis outcomes (Kt/V, ultrafiltration achievement, treatment time) were compared between sessions with and without glucose bolus for IDH. Factors associated with IDH frequency were identified by multivariate linear regression. A total of 4,268 unplanned interventions were recorded, with glucose bolus for IDH being the most frequent (2,734 events, 64.1%) but accounting for only 1.9% of the total costs of all unplanned interventions. Glucose bolus rapidly increased systolic blood pressure (15.2 ± 5.8 mmHg) within 5 min, with effects lasting 65.8 ± 22.5 min. Diabetic patients showed greater pressure response and longer duration compared to non-diabetics. Sessions with glucose bolus achieved significantly higher Kt/V (1.44 ± 0.20 vs. 1.28 ± 0.24, P < 0.001), ultrafiltration completion rate (94.8% vs. 80.2%, P < 0.001), and lower premature termination rate (5.7% vs. 19.9%, P < 0.001) compared to sessions without glucose bolus. Kt/V > 2.0 was independently associated with increased IDH frequency (β = 7.18, P < 0.001). Hypertonic glucose bolus is a frequent, low-cost intervention that was associated with restoration of blood pressure and allowed patients to complete dialysis, thereby achieving adequate Kt/V. However, excessively high Kt/V may predispose patients to recurrent IDH, warranting careful prescription adjustment.

BMC Nephrology
Chinese PLA General Hospital (CN), Suzhou Municipal Hospital (CN)
Openalex Percentile: Top 13%
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.